Spots Global Cancer Trial Database for cd 19+22
Every month we try and update this database with for cd 19+22 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| CAR-T for Children With Relapsed and Refractory Acute Lymphoblastic Leukemia | NCT04626765 | Childhood Acute... | CD19 CAR-T CD22 CAR-T CD 19+22 Fludarabine Cyclophosphamid... | 1 Year - 18 Years | Hebei Senlang Biotechnology Inc., Ltd. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
